Literature DB >> 271038

Metastatic osteosarcoma to lung: a clinicopathologic study of surgical biopsies and resections.

D Dunn, L P Dehner.   

Abstract

Metastatic tumor to the lungs is one of the most important factors in the poor prognosis of primary osteosarcoma of bone. Until recently, pulmonary resection alone was the only therapeutic method available to salvage these patients. Previous investigators have reviewed a number of clinical and pathologic parameters which may possibly relate to the prognosis of osteosarcoma and the occurrence of pulmonary metastases. The pathologic features of these latter lesions have received little attention other than to state that they generally are less differentiated than the primary tumor. A review of multiple pulmonary nodules resected from 15 patients has demonstrated that 66% of all lesions were essentially identical to the primary tumor. The 5-year survival from the original amputation was 33% in this series; however, it was not possible to prognosticate a favorable outcome from the metastasis, a similar type of observation which has been made by others in relation to the primary osteosarcoma.

Entities:  

Mesh:

Year:  1977        PMID: 271038     DOI: 10.1002/1097-0142(197712)40:6<3054::aid-cncr2820400644>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.

Authors:  G Bulut; S-H Hong; K Chen; E M Beauchamp; S Rahim; G W Kosturko; E Glasgow; S Dakshanamurthy; H-S Lee; I Daar; J A Toretsky; C Khanna; A Uren
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

2.  Treatment of osteogenic sarcoma that had metastasized to the lungs--25-year survival of a patient.

Authors:  F D Hankins; D A DeSanto
Journal:  West J Med       Date:  1980-03

3.  Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.

Authors:  Heidi M Namløs; Stine H Kresse; Christoph R Müller; Jørn Henriksen; Rita Holdhus; Gunnar Sæter; Oyvind S Bruland; Bodil Bjerkehagen; Vidar M Steen; Ola Myklebost
Journal:  Sarcoma       Date:  2012-02-28

4.  Molecular alterations associated with osteosarcoma development.

Authors:  Kosei Ando; Kanji Mori; Franck Verrecchia; Baud'huin Marc; Françoise Rédini; Dominique Heymann
Journal:  Sarcoma       Date:  2012-02-15

5.  Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

Authors:  Ehud Segal; Huaizhong Pan; Paula Ofek; Taturo Udagawa; Pavla Kopecková; Jindrich Kopecek; Ronit Satchi-Fainaro
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

Review 6.  C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.

Authors:  Jian-Hua Yi; Dong Wang; Zhi-Yong Li; Jun Hu; Xiao-Feng Niu; Xiao-Lin Liu
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.